Company / FCF Margin
Cardiff Oncology, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-6402.5%
FY2025
5-year range
-9022.3% / -4515.3%
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -9022.3% in FY2023 to -4515.3% in FY2021.
Based on SEC 10-K filings.
-6402.5% in FY2025 with a 5-year CAGR of -1887.1%.
Improved from -9022.3% to -6402.5% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +72.4pp
- 5-Year Change
- -1887.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 0.7% year-over-year.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6402.5% | +0.7% |
| FY2024 | -6448.6% | +28.5% |
| FY2023 | -9022.3% | -39.3% |
| FY2022 | -6474.9% | -43.4% |
| FY2021 | -4515.3% | +0.0% |
| FY2020 | -4515.4% | +17.2% |
| FY2019 | -5451.1% | -17.8% |
| FY2018 | -4626.4% | +44.7% |
| FY2017 | -8361.5% | -79.0% |
| FY2016 | -4672.3% | +40.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026